Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy
According to data from the U.S. National Cancer Institute, cancer is one of the leading causes of death worldwide with approximately 14 million new cases and 8.2 million cancer-related deaths in 2018. More than 60% of the new annual cases in the world occur in Africa, Asia, Central America, and Sout...
Main Authors: | Miguel Angel Galván Morales, Raúl Barrera Rodríguez, Julio Raúl Santiago Cruz, Luis M. Teran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/23/5686 |
Similar Items
-
Immunotherapy in genitourinary malignancies
by: Kathan Mehta, et al.
Published: (2017-04-01) -
Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
by: Mattia Garutti, et al.
Published: (2021-04-01) -
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
by: Adel Naimi, et al.
Published: (2022-04-01) -
Immunotherapy Updates in Advanced Hepatocellular Carcinoma
by: Amisha Singh, et al.
Published: (2021-04-01) -
Immunotherapies for advanced hepatocellular carcinoma
by: Li-Yang Sun, et al.
Published: (2023-03-01)